The molecular docking analysis data of beta-caryophyllene with the insulindownstream signaling molecules such as IRS-1, cSrc and Akt reveals its ability and further studies are needed to elucidate its complete mechanism of action against type-2 diabetes. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.